Rare diseases
Investigational molecules
Locations
Oskar-Maria-Graf-Ring 51, Ramersdorf-Perlach, 81737 Munich, Germany
Muenchen Klinik gGmbH in Munich, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Colorectal cancer metastatic, Non-small cell lung cancer metastatic, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.
At Muenchen Klinik gGmbH, the cardiology team is investigating innovative approaches to manage heart attacks, focusing on patients at risk of a recurrent event. The study evaluates the effectiveness of a self‑administered medication to quickly address symptoms of acute myocardial infarction, aiming to improve early treatment outcomes and reduce hospital admissions.
The research involves a multidisciplinary team of 13 investigators and leverages the hospital’s intensive care expertise in Munich to advance cardiovascular care.
The oncology department is conducting cutting‑edge trials in metastatic colorectal cancer, particularly in patients whose tumors exhibit MSI‑High or mismatch repair deficiency. By testing novel immunotherapy combinations, including agents such as MK‑1308A alongside established checkpoint inhibitors, the goal is to enhance tumor response rates and provide new treatment options for advanced disease.
With 13 dedicated investigators, the Munich site is positioned to contribute valuable data to the global effort against colorectal cancer.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
GermanyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
GermanyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
GermanyA Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is
GermanyStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
GermanyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
GermanyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
GermanyStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Effectiveness of GP2 and Sargramostim for HER2 Positive Breast Cancer Patients with Residual Disease or High-Risk After Standard Therapy
GermanyLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
GermanyStudy of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients
GermanyRandomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
